Mentoring in Kidney Health to Improve Equity

肾脏健康指导以提高公平性

• 批准号: 10808767
• 负责人: Michal L Melamed
• 金额: $ 16.52万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-07 至 2028-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10808767
• 关键词: Adult; Advisory Committees; Alkalies; American; Appointment; Area; Attention; Award; Biological Markers; Black race; Cardiovascular Diseases; Caring; Child; Childhood; Cities; Clinical; Clinical Research; Clinical Trials; Collaborations; Data; Educational workshop; Equity; Faculty; Fellowship; Fellowship Program; Funding; Grant; Health; Hematology; Hemodialysis; Home; Hospitals; Individual; Institution; Internal Medicine; International; Joints; Kidney; Kidney Diseases; Leadership; Literature; Medical; Medical Students; Medical center; Medicine; Mentored Clinical Scientist Development Program; Mentored Patient-Oriented Research Career Development Award; Mentors; Mentorship; Metabolic acidosis; Methods; Modeling; National Institute of Diabetes and Digestive and Kidney Diseases; Nephrology; New York; Paper; Pathway interactions; Patients; Peripheral; Personal Satisfaction; Positioning Attribute; Postdoctoral Fellow; Publishing; Qualifying; Recommendation; Recording of previous events; Renaissance; Reporting; Research; Research Personnel; Research Training; Resolution; Role; Science; Societies; Sodium Bicarbonate; Spottings; Students; TNFSF15 gene; Time; Training; Underrepresented Populations; United States National Institutes of Health; Universities; Vascular calcification; Woman; Work; Writing; X-Ray Computed Tomography; bone; bone health; career; career development; clinical epidemiology; college; design; doctoral student; ethnic minority; experience; health care delivery; health equity; improved; innovation; interest; leadership development; medical schools; meetings; member; next generation; novel; patient population; peer coaching; potassium citrate; pre-doctoral; programs; racial minority population; randomized placebo controlled trial; randomized, clinical trials; recruit; responsible research conduct; secondary analysis; skills; social health determinants; symposium; undergraduate student; urologic; women faculty

Abstract Dr. Melamed is an internationally known kidney health investigator and award-winning mentor. She has mentored 16 post-doctoral fellows in Internal Medicine and Pediatric Nephrology. Her earliest trainees currently hold R-level grants from the NIH. She has published over 130 pa- pers in the medical literature and has been continuously funded by the NIDDK since 2007. Her research includes important work on metabolic acidosis in kidney and bone health and innovative models of care in kidney disease including group-based care and the use of peer mentors in patients requiring in-center hemodialysis treatment. She is currently an MPI on 2 R01 grants. One is for a randomized clinical trial of potassium citrate to evaluate effects on bone in kidney disease using state of the art High Resolution peripheral-Quantitative Computed Tomography (HR- pQCT). The other is a secondary analysis of biomarkers of volume expansion and vascular cal- cification combining data from 3 separate (n=395) randomized, placebo controlled trials of sodium bicarbonate in patients with kidney disease. Dr. Melamed is committed to mentoring investigators from Diverse Backgrounds. She has attended multiple career development workshops on men- toring and plans on using the funding from this award to continue building her skills through work- shops, intensive one-on-one mentoring of trainees, and meeting with an Advisory Committee that will help her to become more attuned to the needs of Diverse Trainees. Her commitment to train- ing junior investigators is evidenced by her writing and obtaining funding for several training grants including being the contact MPI for an NIDDK-funded U2C/TL1 award entitled the “New York Consortium for Training in Kidney, Urological and Hematological Research”, a consortium that includes the Albert Einstein College of Medicine, Columbia University Irving Medical Center, the Icahn School of Medicine at Mount Sinai, and the Renaissance School of Medicine at Stony Brook. There is an additional pathway program for students at the City University of New York. This training grant, which includes 7 post-doctoral fellow and 3 pre-doctoral fellow training spots, brings together the 4 institutions to improve collaborations in these important research areas. She has access to a diverse candidate pool at Einstein and has successfully mentored several post- doctoral fellows, including several Pediatric Nephrologists, from Diverse Backgrounds to aca- demic careers in Nephrology. In sum, Dr. Melamed is an established, award-winning mentor with a successful history of mentoring researchers from Diverse Backgrounds. This award will protect her time to be able to mentor additional trainees.

抽象的 Melamed 博士是国际知名的肾脏健康研究者，屡获殊荣 她指导了16名内科和小儿肾脏病学博士后。 她最早的学员目前拥有 NIH 的 R 级资助。她已发表了 130 多篇论文。 她是医学文献领域的专家，自 2007 年以来一直受到 NIDDK 的资助。 研究包括关于肾脏和骨骼健康的代谢性酸中毒的重要工作以及创新 肾脏疾病的护理模式，包括基于团体的护理和使用同伴导师 需要中心血液透析治疗的患者 她目前是 2 R01 补助金的 MPI。 用于一项柠檬酸钾的随机临床试验，以评估肾脏疾病对骨骼的影响 使用最先进的高分辨率外围定量计算机断层扫描（HR- pQCT）另一个是对容量扩张和血管钙生物标志物的二次分析。 结合来自 3 个独立 (n=395) 钠的随机、安慰剂对照试验的数据进行了合并 Melamed 博士致力于指导研究人员使用碳酸氢盐治疗肾病患者。 她来自不同的背景，参加过多个关于男性的职业发展研讨会。 托林并计划利用该奖项的资金继续通过工作培养她的技能- 商店、对受训者进行密集的一对一指导，以及与咨询委员会的会议， 将帮助她更加适应多元化学员的需求。她对培训的承诺。 她的写作和获得多项培训资助的资金证明了她对初级研究人员的支持 包括作为 NIDDK 资助的 U2C/TL1 奖项的联系人 MPI，该奖项名为“纽约 肾脏、泌尿科和血液学研究培训联盟”，该联盟 包括阿尔伯特·爱因斯坦医学院、哥伦比亚大学欧文医学中心、 西奈山伊坎医学院和斯托尼文艺复兴医学院 布鲁克。纽约城市大学还有一个针对学生的预科课程。 该培训资助包括7个博士后研究员和3个博士前研究员培训名额， 将 4 个机构聚集在一起，以改善这些重要研究领域的合作。 可以接触到爱因斯坦的多元化候选人库，并成功指导了多个职位- 博士研究员，包括几位儿科肾病专家，来自不同的背景 总之，Melamed 博士是一位久负盛名、屡获殊荣的导师。 该奖项将保护来自不同背景的研究人员的成功指导历史。 她有时间指导更多的学员。